Graf Acquisition Corp. IV: insider trades · United States · SEC (Form 4)

About Graf Acquisition Corp. IV

Graf Acquisition Corp. IV (ticker: GFOR) is a United States-listed SPAC traded on the NYSE, which means it is primarily a financial structuring vehicle rather than a traditional operating company. Incorporated in Delaware in 2021, the company was formed to pursue a merger, share exchange, asset acquisition, stock purchase, recapitalization, or another similar business combination with one or more businesses that were not identified at the time of its IPO. Its headquarters are in The Woodlands, Texas, United States. For investors, the key analytical question is not product demand or unit economics, but the sponsor’s ability to source an attractive target, negotiate a workable transaction, and close it within the relevant regulatory timetable. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1845459/000141057823000580/gfor-20221231x10k.htm?utm_source=openai)) Historically, Graf Acquisition Corp. IV fits into the broader SPAC strategy associated with serial SPAC sponsor James Graf. The company went public in 2021 and later announced a business combination with NKGen Biotech, a biotechnology company focused on immunotherapy-related solutions, illustrating the sponsor’s preference for growth-oriented targets rather than mature cash-generating assets. Following completion of the merger, the company changed its name as part of the standard SPAC conversion process. This makes GFOR best understood as a capital-markets instrument whose value depends heavily on deal execution, redemptions, and the market’s reception to the combined entity after closing. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1845459/000110465923036618/tm2310427d1_ex99-1.htm?utm_source=openai)) From a business-model perspective, GFOR does not have conventional product lines or services in the way an industrial, consumer, or technology company would. Its core “business line” is acquisition execution: identifying a target, conducting due diligence, structuring the transaction, securing shareholder approval, and supporting the transition to a public operating company. In competitive terms, SPACs compete for a limited pool of private companies seeking a public listing, so the sponsor’s track record, network, credibility, and ability to deliver financing certainty become the main differentiators. That is especially important when markets are selective and investors are scrutinizing dilution, warrant overhang, and post-merger operating prospects. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1845459/000141057823000580/gfor-20221231x10k.htm?utm_source=openai)) Geographically, the company is rooted in the United States, with its administrative base in Texas and its listing on the NYSE. Its target search, however, can be broader than the domestic footprint, depending on the candidate business and transaction structure. Recent notable developments have centered on the business combination and subsequent insider/Form 4 activity tied to the sponsor and post-closing share distributions. For international equity investors evaluating GFOR, the critical point is that this is a special situation: the real investment case is driven by the quality of the merger outcome, not by recurring standalone operations or a diversified product portfolio. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1845459/000121390024063321/ea0206181-04.pdf?utm_source=openai))